{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:43:33Z","timestamp":1791996213942,"version":"4.4.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The co-reactivation of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in patients undergoing hematopoietic stem cell transplantation (HSCT) has been found. Research has shown that the reactivation of CMV or EBV is closely related to poor HSCT outcomes. In this study, we describe the clinical characteristics of HSCT patients with co-reactivation of CMV and EBV. We retrospectively reviewed the medical records of 327 patients who underwent HSCT at the Peking University People\u2019s Hospital Institute of Hematology. Co-reactivation of CMV and EBV was observed in a total of 75 patients (22.9%) who also had a higher incidence of hemorrhagic cystitis (P=0.000). HSCT patients with CMV and co-reactivation of CMV and EBV had a significantly lower 1-year overall survival (OS; P=0.050). Further, COX regression analysis showed that viral infection was a risk factor for 1-year OS (HR, 12.625 for co-reactivation <jats:italic>vs<\/jats:italic>. no reactivation, p=0.021, and HR 13.580 for CMV reactivation <jats:italic>vs<\/jats:italic>. no reactivation, P=0.013). In conclusion, the patients with CMV reactivation had poorer outcome after HSCT regardless of EBV reactivation.<\/jats:p>","DOI":"10.3389\/fcimb.2022.818167","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:49:37Z","timestamp":1648554577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"12","author":[{"given":"Shan-shan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3","article-title":"Immunoreactivation of Epstein-Barr Virus Due to Cytomegalovirus Primary Infection","volume":"56","author":"Aalto","year":"1998","journal-title":"J. Med. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e13396","DOI":"10.1111\/tid.13396","article-title":"Coinfection Rates and Clinical Outcome Data for Cytomegalovirus and Epstein-Barr Virus in Post-Transplant Patients: A Systematic Review of the Literature","volume":"22","author":"Anderson-Smits","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/ejh.12260","article-title":"Controlled Epstein-Barr Virus Reactivation After Allogeneic Transplantation is Associated With Improved Survival","volume":"92","author":"Auger","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00430-019-00629-2","article-title":"Clinical Utility of Measuring Epstein-Barr Virus-Specific Cell-Mediated Immunity After HSCT in Addition to Virological Monitoring: Results From a Prospective Study","volume":"208","author":"Chiereghin","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/vaccines9060610","article-title":"Association Between Antiviral Prophylaxis and Cytomegalovirus and Epstein-Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant","volume":"7","author":"Diop","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood.2019000956","article-title":"How I Treat CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"135","author":"Einsele","year":"2020","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e14052","DOI":"10.1111\/petr.14052","article-title":"Risk Factors for Post-Transplant Epstein-Barr Virus Events in Pediatric Recipients of Hematopoietic Stem Cell Transplants","volume":"25","author":"Enok Bonong","year":"2021","journal-title":"Pediatr. Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijid.2016.03.025","article-title":"Herpesvirus Infections in Hematopoietic Stem Cell Transplant Recipients Seropositive for Human Cytomegalovirus Before Transplantation","volume":"46","author":"Fan","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","article-title":"Natural Killer Cell Receptors: New Biology and Insights Into the Graft-Versus-Leukemia Effect","volume":"100","author":"Farag","year":"2002","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1182\/blood-2011-04-347070","article-title":"NK Cell Education After Allogeneic Transplantation: Dissociation Between Recovery of Cytokine-Producing and Cytotoxic Functions","volume":"118","author":"Foley","year":"2011","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020328","article-title":"Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders After Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes","volume":"12","author":"Fujimoto","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/bmt.2014.298","article-title":"Impact of Epstein Barr Virus-Related Complications After High-Risk Allo-SCT in the Era of Pre-Emptive Rituximab","volume":"50","author":"Garcia-Cadenas","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/ajt.15515","article-title":"Cytomegalovirus (CMV) Infection and Risk of Mortality in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT): A Systematic Review, Meta-Analysis, and Meta-Regression Analysis","volume":"19","author":"Gimenez","year":"2019","journal-title":"Am. J. Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV Reactivation After Allogeneic HCT and Relapse Risk: Evidence for Early Protection in Acute Myeloid Leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2010-02-269381","article-title":"NK-Cell Education is Shaped by Donor HLA Genotype After Unrelated Allogeneic Hematopoietic Stem Cell Transplantation","volume":"117","author":"Haas","year":"2011","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.4049\/jimmunol.1303211","article-title":"Cutting Edge: NKG2C(hi)CD57+ NK Cells Respond Specifically to Acute Infection With Cytomegalovirus and Not Epstein-Barr Virus","volume":"192","author":"Hendricks","year":"2014","journal-title":"J. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The Cumulative Burden of Double-Stranded DNA Virus Detection After Allogeneic HCT is Associated With Increased Mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbmt.2008.11.025","article-title":"Treatment of Acute Leukemia With Unmanipulated HLA-Mismatched\/Haploidentical Blood and Bone Marrow Transplantation","volume":"15","author":"Huang","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bjh.15037","article-title":"Inverse Correlation of Vdelta2(+) T-Cell Recovery With EBV Reactivation After Haematopoietic Stem Cell Transplantation","volume":"180","author":"Liu","year":"2018","journal-title":"Br. J. Haematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the Management of Cytomegalovirus Infection in Patients With Haematological Malignancies and After Stem Cell Transplantation From the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.4049\/jimmunol.1301046","article-title":"A Distinct Subpopulation of Human NK Cells Restricts B Cell Transformation by EBV","volume":"191","author":"Lunemann","year":"2013","journal-title":"J. Immunol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.732826","article-title":"CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3760\/cma.j.issn.0376-2491.2014.40.005","article-title":"Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation Patients With Co-Activation of Cytomegalovirus and Epstein-Barr Virus","volume":"94","author":"Song","year":"2014","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.bbmt.2014.08.010","article-title":"Cytomegalovirus Infection in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation in Portugal: A Five-Year Retrospective Review","volume":"20","author":"Sousa","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/infdis\/jiab212","article-title":"Cytomegalovirus Viral Load Kinetics Predict Cytomegalovirus End-Organ Disease and Mortality After Hematopoietic Cell Transplant","volume":"224","author":"Stern","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"179 e171","DOI":"10.1016\/j.cmi.2015.10.017","article-title":"Increased Risk of Infections and Infection-Related Mortality in Children Undergoing Haematopoietic Stem Cell Transplantation Compared to Conventional Anticancer Therapy: A Multicentre Nationwide Study","volume":"22","author":"Styczynski","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr Virus Infections and Post-Transplant Lymphoproliferative Disorders in Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) Guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early Cytomegalovirus Reactivation Remains Associated With Increased Transplant-Related Mortality in the Current Era: A CIBMTR Analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bbmt.2010.08.023","article-title":"Superior Graft-Versus-Leukemia Effect Associated With Transplantation of Haploidentical Compared With HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison","volume":"17","author":"Wang","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1182\/bloodadvances.2020002417","article-title":"Antineoplastic and Anti-Inflammatory Effects of Bortezomib on Systemic Chronic Active EBV Infection","volume":"5","author":"Yoshimori","year":"2021","journal-title":"Blood Adv."},{"key":"B31","doi-asserted-by":"publisher","first-page":"E491","DOI":"10.1111\/ctr.12172","article-title":"Epstein-Barr Virus Reactivation in Allogeneic Stem Cell Transplantation Is Highly Related to Cytomegalovirus Reactivation","volume":"27","author":"Zallio","year":"2013","journal-title":"Clin. Transpl."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.620891","article-title":"Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"108727","DOI":"10.1016\/j.clim.2021.108727","article-title":"Natural Killer Cells Play an Important Role in Virus Infection Control: Antiviral Mechanism, Subset Expansion and Clinical Application","volume":"227","author":"Zuo","year":"2021","journal-title":"Clin. Immunol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.818167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:49:40Z","timestamp":1648554580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.818167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":33,"alternative-id":["10.3389\/fcimb.2022.818167"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.818167","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]},"article-number":"818167"}}